Skip to main content
Top
Published in: Clinical Rheumatology 9/2007

01-09-2007 | Review Article

The development of systemic sclerosis classification criteria

Authors: Jennifer G. Walker, Janet Pope, Murray Baron, Sharon LeClercq, Marie Hudson, Suzanne Taillefer, Steven M. Edworthy, Oleg Nadashkevich, Marvin J. Fritzler

Published in: Clinical Rheumatology | Issue 9/2007

Login to get access

Abstract

Systemic sclerosis (SSc) is a rare connective tissue disorder whose aetiology remains obscure, although environmental and genetic influences are likely to play a role. Disease registries have contributed to enhancing our understanding of this debilitating illness, but without sensitive, specific, and extensively validated classification criteria, accurate comparison between registries and the identification of patients suitable for clinical trials can be problematic. The American College of Rheumatology (ACR) criteria, published in 1980, have become outdated as our understanding of disease specific autoantibodies and nailfold capillaroscopy has improved. In addition, the sensitivity of the ACR criteria is low with respect to limited SSc. Although subsequent classification systems have been proposed, none has gained universal approval. The two- versus three-subset disease model remains a point of debate. Newly derived criteria are likely to draw upon the older classification systems as well as incorporating up-to-date diagnostic techniques and biomarkers. Validation will be critical before their use becomes widespread.
Literature
1.
go back to reference Tan FK (2003) Systemic sclerosis: the susceptible host (genetics and environment). Rheum Dis Clin North Am 29:211–237PubMedCrossRef Tan FK (2003) Systemic sclerosis: the susceptible host (genetics and environment). Rheum Dis Clin North Am 29:211–237PubMedCrossRef
2.
go back to reference Zandman-Goddard G, Tweezer-Zaks N, Shoenfeld Y (2005) New therapeutic strategies for systemic sclerosis—a critical analysis of the literature. Clin Dev Immunol 12(3):165–173PubMedCrossRef Zandman-Goddard G, Tweezer-Zaks N, Shoenfeld Y (2005) New therapeutic strategies for systemic sclerosis—a critical analysis of the literature. Clin Dev Immunol 12(3):165–173PubMedCrossRef
3.
go back to reference Mayes MD, Giannini EH, Pachman LM et al (1997) Connective tissue disease registries. Arthritis Rheum 40:1556–1559PubMedCrossRef Mayes MD, Giannini EH, Pachman LM et al (1997) Connective tissue disease registries. Arthritis Rheum 40:1556–1559PubMedCrossRef
4.
go back to reference Barnett AJ, Miller MH, Littlejohn GO (1988) A survival study of patients with scleroderma diagnosed over 30 years (1953–1983): the value of a simple cutaneous classification in the early stages of the disease. J Rheumatol 15(2):276–283 (Feb)PubMed Barnett AJ, Miller MH, Littlejohn GO (1988) A survival study of patients with scleroderma diagnosed over 30 years (1953–1983): the value of a simple cutaneous classification in the early stages of the disease. J Rheumatol 15(2):276–283 (Feb)PubMed
5.
go back to reference Maricq HR, Valter I (2004) A working classification of scleroderma spectrum disorders: a proposal and the results of testing on a sample of patients. Clin Exp Rheumatol 22(3 Suppl 33):S5–S13 (Jan–Feb)PubMed Maricq HR, Valter I (2004) A working classification of scleroderma spectrum disorders: a proposal and the results of testing on a sample of patients. Clin Exp Rheumatol 22(3 Suppl 33):S5–S13 (Jan–Feb)PubMed
6.
go back to reference Steen VD, Oddis CV, Conte CG et al (1997) Incidence of systemic sclerosis in Allegheny county, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963–1982. Arthritis Rheum 40(3):441–445PubMedCrossRef Steen VD, Oddis CV, Conte CG et al (1997) Incidence of systemic sclerosis in Allegheny county, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963–1982. Arthritis Rheum 40(3):441–445PubMedCrossRef
7.
go back to reference LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28:1573–1576PubMed LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28:1573–1576PubMed
8.
go back to reference Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23(5):581–590CrossRef Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23(5):581–590CrossRef
9.
go back to reference LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202–205 (Feb)PubMed LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202–205 (Feb)PubMed
10.
go back to reference Nadashkevich N, Davis P, Fritzler MJ (2004) A proposal of criteria for the classification of systemic sclerosis. Med Sci Monit 10(11):CR615–CR621PubMed Nadashkevich N, Davis P, Fritzler MJ (2004) A proposal of criteria for the classification of systemic sclerosis. Med Sci Monit 10(11):CR615–CR621PubMed
11.
go back to reference Fries JF, Hochberg MC, Medsger TA Jr et al (1994) Criteria for rheumatic disease. Different types and different functions. Arthritis Rheum 37(4):454–462PubMedCrossRef Fries JF, Hochberg MC, Medsger TA Jr et al (1994) Criteria for rheumatic disease. Different types and different functions. Arthritis Rheum 37(4):454–462PubMedCrossRef
12.
go back to reference Rudwaleit M, Khan MA, Sieper J (2005) The challenge of diagnosis and classification in early ankylosing spondylitis. Arthritis Rheum 52(4):1000–1008PubMedCrossRef Rudwaleit M, Khan MA, Sieper J (2005) The challenge of diagnosis and classification in early ankylosing spondylitis. Arthritis Rheum 52(4):1000–1008PubMedCrossRef
13.
go back to reference Classification and response criteria subcommittee of the American College of Rheumatology Committee on Quality Measures (2006) Development of classification and response criteria for rheumatic diseases. Arthritis Rheum (Arthritis Care and Research) 55(3):348–352CrossRef Classification and response criteria subcommittee of the American College of Rheumatology Committee on Quality Measures (2006) Development of classification and response criteria for rheumatic diseases. Arthritis Rheum (Arthritis Care and Research) 55(3):348–352CrossRef
14.
go back to reference Felson DT, Anderson JJ (1995) Methodological and statistical approaches to criteria development in rheumatic diseases. Bailliere’s Clin Rheumatol 9:253–266CrossRef Felson DT, Anderson JJ (1995) Methodological and statistical approaches to criteria development in rheumatic diseases. Bailliere’s Clin Rheumatol 9:253–266CrossRef
15.
go back to reference Maricq HR, Weinrich MC, Keil JE et al (1989) Prevalence of the scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 32(8):998–1006PubMedCrossRef Maricq HR, Weinrich MC, Keil JE et al (1989) Prevalence of the scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 32(8):998–1006PubMedCrossRef
16.
go back to reference Steen V, Medsger TA Jr (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43(11):2437–2444PubMedCrossRef Steen V, Medsger TA Jr (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43(11):2437–2444PubMedCrossRef
17.
go back to reference Steen V, Medsger TA Jr (2001) Improvement in skin thickening in systemic sclerosis associated with improved survival. Arthritis Rheum 44(12):2828–2835PubMedCrossRef Steen V, Medsger TA Jr (2001) Improvement in skin thickening in systemic sclerosis associated with improved survival. Arthritis Rheum 44(12):2828–2835PubMedCrossRef
18.
go back to reference Giordano M, Valentini G, Migliaresi S et al (1986) Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. J Rheumatol 13:911–916PubMed Giordano M, Valentini G, Migliaresi S et al (1986) Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. J Rheumatol 13:911–916PubMed
19.
go back to reference Ferri C, Valentini G, Cozzi F et al (2002) Systemic sclerosis: demographic, clinical and serologic features and survival in 1012 Italian patients. Medicine (Baltimore) 81(2):139–153CrossRef Ferri C, Valentini G, Cozzi F et al (2002) Systemic sclerosis: demographic, clinical and serologic features and survival in 1012 Italian patients. Medicine (Baltimore) 81(2):139–153CrossRef
20.
go back to reference Scussel-Lonzetti L, Joyal F, Raynauld JP et al (2002) Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 81(2):154–167CrossRef Scussel-Lonzetti L, Joyal F, Raynauld JP et al (2002) Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 81(2):154–167CrossRef
21.
go back to reference Tuffanelli DL, Winkelmann RK (1962) Diffuse systemic scleroderma. A comparison with acrosclerosis. Ann Intern Med 57:198–203PubMed Tuffanelli DL, Winkelmann RK (1962) Diffuse systemic scleroderma. A comparison with acrosclerosis. Ann Intern Med 57:198–203PubMed
22.
go back to reference Masi AT (1988) Classification of systemic sclerosis (scleroderma): relationship of cutaneous subgroups in early disease to outcome and serologic reactivity. J Rheumatol 15(6):894–898 (Jun)PubMed Masi AT (1988) Classification of systemic sclerosis (scleroderma): relationship of cutaneous subgroups in early disease to outcome and serologic reactivity. J Rheumatol 15(6):894–898 (Jun)PubMed
23.
go back to reference Jacobsen S, Halberg P, Ullman S (1998) Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol 37:750–755PubMedCrossRef Jacobsen S, Halberg P, Ullman S (1998) Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol 37:750–755PubMedCrossRef
24.
go back to reference Reveille JD, Solomon DH, The American College of Rheumatology Ad hoc Committee on Immunologic Testing Guidelines (2003) Evidence-based guidelines for the use of immunologic tests: anticentromere, Sl–70 and nucleolar antibodies. Arthritis Rheum 49(3):399–412PubMedCrossRef Reveille JD, Solomon DH, The American College of Rheumatology Ad hoc Committee on Immunologic Testing Guidelines (2003) Evidence-based guidelines for the use of immunologic tests: anticentromere, Sl–70 and nucleolar antibodies. Arthritis Rheum 49(3):399–412PubMedCrossRef
25.
go back to reference Arnett F, Reveille JD, Goldstein R et al (1996) Autoantibodies to fibrillarin in systemic sclerosis (scleroderma): an immunogenetic, serological and clinical analysis. Arthritis Rheum 39:1151–1160PubMedCrossRef Arnett F, Reveille JD, Goldstein R et al (1996) Autoantibodies to fibrillarin in systemic sclerosis (scleroderma): an immunogenetic, serological and clinical analysis. Arthritis Rheum 39:1151–1160PubMedCrossRef
26.
go back to reference Wollheim FA (2005) Classification of systemic sclerosis. Visions and reality. Rheumatology (Oxford) 44:1212–1216CrossRef Wollheim FA (2005) Classification of systemic sclerosis. Visions and reality. Rheumatology (Oxford) 44:1212–1216CrossRef
27.
go back to reference Cepeda EJ, Reveille JD (2004) Antibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance. Curr Opin Rheumatol 16:723–732PubMedCrossRef Cepeda EJ, Reveille JD (2004) Antibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance. Curr Opin Rheumatol 16:723–732PubMedCrossRef
28.
go back to reference Fritzler MJ (2006) Advances and applications of multiplexed diagnostic technologies in autoimmune diseases. Lupus 15:422–427PubMedCrossRef Fritzler MJ (2006) Advances and applications of multiplexed diagnostic technologies in autoimmune diseases. Lupus 15:422–427PubMedCrossRef
29.
go back to reference Steen VD, Powell DL (1988) Clinical correlations and prognosis based on serum autoantibodies in patients with progressive systemic sclerosis. Arthritis Rheum 31:196–203PubMedCrossRef Steen VD, Powell DL (1988) Clinical correlations and prognosis based on serum autoantibodies in patients with progressive systemic sclerosis. Arthritis Rheum 31:196–203PubMedCrossRef
30.
go back to reference Bernstein RM, Steigerwald JC, Tan EM (1982) Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis. Clin Exp Rheumatol 48(1):43–51 Bernstein RM, Steigerwald JC, Tan EM (1982) Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis. Clin Exp Rheumatol 48(1):43–51
31.
go back to reference Satiago M, Baron M, Burlingame RW et al (2007) Antibodies to RNA polymerase III in systemic sclerosis as detected by an ELISA. Arthritis Rheum (Arthritis Care and Research) (submitted for publication, January 2007) Satiago M, Baron M, Burlingame RW et al (2007) Antibodies to RNA polymerase III in systemic sclerosis as detected by an ELISA. Arthritis Rheum (Arthritis Care and Research) (submitted for publication, January 2007)
32.
go back to reference Tormey VJ, Bunn CC, Denton CP et al (2001) Anti-fibrillarin antibodies in systemic sclerosis. Rheumatology (Oxford) 40(10):1157–1162CrossRef Tormey VJ, Bunn CC, Denton CP et al (2001) Anti-fibrillarin antibodies in systemic sclerosis. Rheumatology (Oxford) 40(10):1157–1162CrossRef
33.
go back to reference Brown GE, O’Leary PA (1925) Skin capillaries in scleroderma. Arch Intern Med 36:73–88 Brown GE, O’Leary PA (1925) Skin capillaries in scleroderma. Arch Intern Med 36:73–88
34.
go back to reference Maricq HR, LeRoy EC (1973) Patterns of finger capillary abnormalities in connective tissue disease by “wide-field” microscopy. Arthritis Rheum 16:619–628PubMedCrossRef Maricq HR, LeRoy EC (1973) Patterns of finger capillary abnormalities in connective tissue disease by “wide-field” microscopy. Arthritis Rheum 16:619–628PubMedCrossRef
35.
36.
go back to reference Maricq HR (1981) Widefield capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum 24(9):1159–1165PubMedCrossRef Maricq HR (1981) Widefield capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum 24(9):1159–1165PubMedCrossRef
37.
go back to reference Cutolo M, Sulli A, Pizzorni C et al (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160PubMed Cutolo M, Sulli A, Pizzorni C et al (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160PubMed
38.
go back to reference Nagy Z, Czirjak L (2004) Nailfold digital capillaroscopy in 447 patients with connectiv tissue disease ad Raynaud’s diseases. J Eur Dermatol Acad Venereol 18:62–68CrossRef Nagy Z, Czirjak L (2004) Nailfold digital capillaroscopy in 447 patients with connectiv tissue disease ad Raynaud’s diseases. J Eur Dermatol Acad Venereol 18:62–68CrossRef
39.
go back to reference Cutolo M, Pizzorni C, Tuccio A et al (2004) Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology (Oxford) 43:719–726CrossRef Cutolo M, Pizzorni C, Tuccio A et al (2004) Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology (Oxford) 43:719–726CrossRef
40.
go back to reference Anderson ME, Allen PD, Moore T et al (2005) Computerized nailfold video capillaroscopy—a new tool for assessment of Rayaud’s phenomenon. J Rheumatol 32:841–848PubMed Anderson ME, Allen PD, Moore T et al (2005) Computerized nailfold video capillaroscopy—a new tool for assessment of Rayaud’s phenomenon. J Rheumatol 32:841–848PubMed
41.
go back to reference Bergman R, Sharony L, Schapira D et al (2003) The handheld dermatoscope as a nail-fold capillaroscopic instrument. Arch Dermatol 139:1027–1030PubMedCrossRef Bergman R, Sharony L, Schapira D et al (2003) The handheld dermatoscope as a nail-fold capillaroscopic instrument. Arch Dermatol 139:1027–1030PubMedCrossRef
42.
go back to reference Baron M, Bell M, Bookman A et al (2007) Office capillaroscopy in systemic sclerosis. Clin Rheum (in press) Baron M, Bell M, Bookman A et al (2007) Office capillaroscopy in systemic sclerosis. Clin Rheum (in press)
43.
go back to reference Capusan I (1972) Curzio’s case of scleroderma (letter). Ann Intern Med 76(1):146PubMed Capusan I (1972) Curzio’s case of scleroderma (letter). Ann Intern Med 76(1):146PubMed
44.
go back to reference Barnett AJ (1978) Scleroderma (progressive systemic sclerosis): progress and course based on a personal series of 118 patients. Med J Aust 2(4):129–134PubMed Barnett AJ (1978) Scleroderma (progressive systemic sclerosis): progress and course based on a personal series of 118 patients. Med J Aust 2(4):129–134PubMed
45.
go back to reference Rodnan GP, Lipinski E, Luksick J (1979) Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum 22(2):130–140PubMedCrossRef Rodnan GP, Lipinski E, Luksick J (1979) Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum 22(2):130–140PubMedCrossRef
46.
go back to reference Akesson A, Wollheim FA (1989) Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma. Br J Rheumatol 28:281–286PubMedCrossRef Akesson A, Wollheim FA (1989) Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma. Br J Rheumatol 28:281–286PubMedCrossRef
47.
go back to reference Vayssairat M, Baudot N, Abuaf N et al (1992) Long-term follow-up study of 164 patients with definite systemic sclerosis: classification considerations. Clin Rheum 11(3):356–363CrossRef Vayssairat M, Baudot N, Abuaf N et al (1992) Long-term follow-up study of 164 patients with definite systemic sclerosis: classification considerations. Clin Rheum 11(3):356–363CrossRef
48.
go back to reference Lonzetti LS, Joyal F, Raynauld JP et al (2001) Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 44(3):735–736 (Mar)PubMedCrossRef Lonzetti LS, Joyal F, Raynauld JP et al (2001) Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 44(3):735–736 (Mar)PubMedCrossRef
Metadata
Title
The development of systemic sclerosis classification criteria
Authors
Jennifer G. Walker
Janet Pope
Murray Baron
Sharon LeClercq
Marie Hudson
Suzanne Taillefer
Steven M. Edworthy
Oleg Nadashkevich
Marvin J. Fritzler
Publication date
01-09-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 9/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0537-x

Other articles of this Issue 9/2007

Clinical Rheumatology 9/2007 Go to the issue